Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.38 |
| ▸ | GALR3 | O60755 | 1/20 | 0.38 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TK1 | P04183 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.35 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | OGA | O60502 | 1/20 | 0.33 |
| ▸ | TK2 | O00142 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9751247 | 1.00 | ADRB1 (0.38) | ADRB1DNMT1GALR3NR2F2LMNA | |
| SCHEMBL10631814 | 0.76 | DNMT1 (0.37) | ADRB1DNMT1GALR3NR2F2LMNA | |
| SCHEMBL27165201 | 0.76 | ADRB1 (0.41) | ADRB1DNMT1GALR3NR2F2LMNA | |
| SCHEMBL7024599 | 0.75 | SLC5A2 (0.47) | LMNASMN1; SMN2 | |
| SCHEMBL3786766 | 0.75 | SLC5A2 (0.47) | LMNASMN1; SMN2 | |
| SCHEMBL1444855 | 0.75 | SLC5A2 (0.47) | LMNASMN1; SMN2 | |
| SCHEMBL2563761 | 0.75 | SLC5A2 (0.47) | LMNASMN1; SMN2 | |
| SCHEMBL4934487 | 0.75 | CYP2A6 (0.43) | LMNA | |
| SCHEMBL9634749 | 0.74 | LMNA (0.37) | ADRB1DNMT1GALR3NR2F2LMNA | |
| SCHEMBL9633782 | 0.74 | LMNA (0.37) | ADRB1DNMT1GALR3NR2F2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0521111-B1 | POLYNUCLEOTIDE CAPTURE ASSAY EMPLOYING IN VITRO AMPLIFICATION | CHIRON CORP (US) | 1998-11-18 | — | — | EP | disclosed |
| EP-0469066-B1 | IMPROVED NUCLEIC ACID HYBRIDIZATION ASSAYS FOR HBV EMPLOYING AMPLIFICATION | CHIRON CORP (US) | 1996-05-29 | — | — | EP | disclosed |
| EP-0317077-B1 | Nucleic acid multimers and amplified nucleic acid hybridization assays using same | CHIRON CORP (US) | 1996-01-31 | — | — | EP | disclosed |
| EP-0469066-A4 | IMPROVED AMPLIFIED NUCLEIC ACID HYBRIDIZATION ASSAYS FOR HBV | — | 1992-07-08 | — | — | EP | disclosed |
| EP-0469066-A1 | IMPROVED AMPLIFIED NUCLEIC ACID HYBRIDIZATION ASSAYS FOR HBV. | CHIRON CORP (US) | 1992-02-05 | — | — | EP | disclosed |
| WO-1990013667-A1 | IMPROVED AMPLIFIED NUCLEIC ACID HYBRIDIZATION ASSAYS FOR HBV | CHIRON CORPORATION (US) | 1990-11-15 | — | — | WO | disclosed |
| EP-0317077-A1 | Nucleic acid multimers and amplified nucleic acid hybridization assays using same | CHIRON CORPORATION (US) | 1989-05-14 | — | — | EP | disclosed |